Sonoma Pharmaceuticals, Inc.

UBS Group AG SNOA
Report date
6/30/2024
Quarter
2024 Q2
Filed
8/14/2024
Shares
11,917
Value ($000)
3
Weight
0.0%
2019 Q4 - 2024 Q2 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).